Global Meningococcal Vaccine Sales Market Report 2024
The global Meningococcal Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Quadrivalent
Bivalent
Others
Segment by Application
Pneumonia
Meningitis
Bacteremia
Others (Arthritis, Conjunctivitis, Urethritis)
The Meningococcal Vaccine market is analysed and market size information is provided by regions (countries).
Segment by Application
, the Meningococcal Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei

Table of Content
1 Meningococcal Vaccine Market Overview
1.1 Meningococcal Vaccine Product Scope
1.2 Meningococcal Vaccine Segment by Type
1.2.1 Global Meningococcal Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 Quadrivalent
1.2.3 Bivalent
1.2.4 Others
1.3 Meningococcal Vaccine Segment by Application
1.3.1 Global Meningococcal Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Bacteremia
1.3.5 Others (Arthritis, Conjunctivitis, Urethritis)
1.4 Meningococcal Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Meningococcal Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Meningococcal Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Meningococcal Vaccine Price Trends (2016-2027)
2 Meningococcal Vaccine Estimates and Forecasts by Region
2.1 Global Meningococcal Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Meningococcal Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Meningococcal Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Meningococcal Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Meningococcal Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Meningococcal Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Meningococcal Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Meningococcal Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Meningococcal Vaccine Estimates and Projections (2016-2027)
2.4.3 China Meningococcal Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Meningococcal Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Meningococcal Vaccine Estimates and Projections (2016-2027)
2.4.6 India Meningococcal Vaccine Estimates and Projections (2016-2027)
3 Global Meningococcal Vaccine Competition Landscape by Players
3.1 Global Top Meningococcal Vaccine Players by Sales (2016-2021)
3.2 Global Top Meningococcal Vaccine Players by Revenue (2016-2021)
3.3 Global Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Meningococcal Vaccine as of 2020)
3.4 Global Meningococcal Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Meningococcal Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Meningococcal Vaccine Market Size by Type
4.1 Global Meningococcal Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Meningococcal Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Meningococcal Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Meningococcal Vaccine Price by Type (2016-2021)
4.2 Global Meningococcal Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Meningococcal Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Meningococcal Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Meningococcal Vaccine Price Forecast by Type (2022-2027)
5 Global Meningococcal Vaccine Market Size by Application
5.1 Global Meningococcal Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Meningococcal Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Meningococcal Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Meningococcal Vaccine Price by Application (2016-2021)
5.2 Global Meningococcal Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Meningococcal Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Meningococcal Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Meningococcal Vaccine Price Forecast by Application (2022-2027)
6 North America Meningococcal Vaccine Market Facts & Figures
6.1 North America Meningococcal Vaccine Sales by Company
6.1.1 North America Meningococcal Vaccine Sales by Company (2016-2021)
6.1.2 North America Meningococcal Vaccine Revenue by Company (2016-2021)
6.2 North America Meningococcal Vaccine Sales Breakdown by Type
6.2.1 North America Meningococcal Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Meningococcal Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Meningococcal Vaccine Sales Breakdown by Application
6.3.1 North America Meningococcal Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Meningococcal Vaccine Sales Breakdown by Application (2022-2027)
7 Europe Meningococcal Vaccine Market Facts & Figures
7.1 Europe Meningococcal Vaccine Sales by Company
7.1.1 Europe Meningococcal Vaccine Sales by Company (2016-2021)
7.1.2 Europe Meningococcal Vaccine Revenue by Company (2016-2021)
7.2 Europe Meningococcal Vaccine Sales Breakdown by Type
7.2.1 Europe Meningococcal Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Meningococcal Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Meningococcal Vaccine Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)
8 China Meningococcal Vaccine Market Facts & Figures
8.1 China Meningococcal Vaccine Sales by Company
8.1.1 China Meningococcal Vaccine Sales by Company (2016-2021)
8.1.2 China Meningococcal Vaccine Revenue by Company (2016-2021)
8.2 China Meningococcal Vaccine Sales Breakdown by Type
8.2.1 China Meningococcal Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Meningococcal Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Meningococcal Vaccine Sales Breakdown by Application
8.3.1 China 311 Sales Breakdown by Application (2016-2021)
8.3.2 China 311 Sales Breakdown by Application (2022-2027)
9 Japan Meningococcal Vaccine Market Facts & Figures
9.1 Japan Meningococcal Vaccine Sales by Company
9.1.1 Japan Meningococcal Vaccine Sales by Company (2016-2021)
9.1.2 Japan Meningococcal Vaccine Revenue by Company (2016-2021)
9.2 Japan Meningococcal Vaccine Sales Breakdown by Type
9.2.1 Japan Meningococcal Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Meningococcal Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Meningococcal Vaccine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Meningococcal Vaccine Market Facts & Figures
10.1 Southeast Asia Meningococcal Vaccine Sales by Company
10.1.1 Southeast Asia Meningococcal Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Meningococcal Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Meningococcal Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Meningococcal Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Meningococcal Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Meningococcal Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia K Dose Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Dose Sales Breakdown by Application (2022-2027)
11 India Meningococcal Vaccine Market Facts & Figures
11.1 India Meningococcal Vaccine Sales by Company
11.1.1 India Meningococcal Vaccine Sales by Company (2016-2021)
11.1.2 India Meningococcal Vaccine Revenue by Company (2016-2021)
11.2 India Meningococcal Vaccine Sales Breakdown by Type
11.2.1 India Meningococcal Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Meningococcal Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Meningococcal Vaccine Sales Breakdown by Application
11.3.1 India Meningococcal Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Meningococcal Vaccine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Meningococcal Vaccine Business
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Business Overview
12.1.3 Novartis Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Meningococcal Vaccine Products Offered
12.1.5 Novartis Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Business Overview
12.2.3 GSK Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK Meningococcal Vaccine Products Offered
12.2.5 GSK Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Meningococcal Vaccine Products Offered
12.3.5 Merck Recent Development
12.4 CSL
12.4.1 CSL Corporation Information
12.4.2 CSL Business Overview
12.4.3 CSL Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 CSL Meningococcal Vaccine Products Offered
12.4.5 CSL Recent Development
12.5 Baxter
12.5.1 Baxter Corporation Information
12.5.2 Baxter Business Overview
12.5.3 Baxter Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Baxter Meningococcal Vaccine Products Offered
12.5.5 Baxter Recent Development
12.6 JN International Medical Corporation
12.6.1 JN International Medical Corporation Corporation Information
12.6.2 JN International Medical Corporation Business Overview
12.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 JN International Medical Corporation Meningococcal Vaccine Products Offered
12.6.5 JN International Medical Corporation Recent Development
12.7 Serum Institute of India
12.7.1 Serum Institute of India Corporation Information
12.7.2 Serum Institute of India Business Overview
12.7.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Serum Institute of India Meningococcal Vaccine Products Offered
12.7.5 Serum Institute of India Recent Development
12.8 Bio-Med
12.8.1 Bio-Med Corporation Information
12.8.2 Bio-Med Business Overview
12.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bio-Med Meningococcal Vaccine Products Offered
12.8.5 Bio-Med Recent Development
12.9 China National Biotec Group
12.9.1 China National Biotec Group Corporation Information
12.9.2 China National Biotec Group Business Overview
12.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 China National Biotec Group Meningococcal Vaccine Products Offered
12.9.5 China National Biotec Group Recent Development
12.10 Hualan Bio
12.10.1 Hualan Bio Corporation Information
12.10.2 Hualan Bio Business Overview
12.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Hualan Bio Meningococcal Vaccine Products Offered
12.10.5 Hualan Bio Recent Development
12.11 Walvax
12.11.1 Walvax Corporation Information
12.11.2 Walvax Business Overview
12.11.3 Walvax Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Walvax Meningococcal Vaccine Products Offered
12.11.5 Walvax Recent Development
12.12 Zhifei
12.12.1 Zhifei Corporation Information
12.12.2 Zhifei Business Overview
12.12.3 Zhifei Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Zhifei Meningococcal Vaccine Products Offered
12.12.5 Zhifei Recent Development
13 Meningococcal Vaccine Manufacturing Cost Analysis
13.1 Meningococcal Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Meningococcal Vaccine
13.4 Meningococcal Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Meningococcal Vaccine Distributors List
14.3 Meningococcal Vaccine Customers
15 Market Dynamics
15.1 Meningococcal Vaccine Market Trends
15.2 Meningococcal Vaccine Drivers
15.3 Meningococcal Vaccine Market Challenges
15.4 Meningococcal Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer